Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Genocea Biosciences Inc (NASDAQ:GNCA)

6.39
Delayed Data
As of Apr 28
 +0.14 / +2.24%
Today’s Change
3.28
Today|||52-Week Range
7.29
+55.10%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues0.000.00670.0K235.0K
 
 
 
Depreciation And Amortization318.0K469.0K1.1M1.8M
 
 
 
 
 
 
Operating ExpensesGross Income-318.0K-469.0K----
 
 
 
General Expenses20.3M33.0M41.0M46.7M
 
 
 
 
 
Research And Development15.7M23.7M28.0M33.1M
 
 
 
 
 
Total Operating Expenses20.7M33.5M42.0M48.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-20.7M-33.5M-41.4M-48.2M
 
 
 
 
 
Extraordinary Charge-422.0K-1.2M0.000.00
 
 
 
Interest Expense On Debt459.0K970.0K1.1M1.7M
 
 
 
 
 
Other Expenses731.0K308.0K0.000.00
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-20.8M-35.3M-42.5M-49.6M
 
 
 
 
 
Net Income-22.4M-35.5M-42.5M-49.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS17.2M15.6M24.5M28.3M
 
 
 
 
 
Shares To Calculate EPS Diluted17.2M15.6M24.5M28.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$75.46-$2.27-$1.74-$1.75
 
 
 
 
 
EPS Diluted-$1.21-$2.27-$1.74-$1.75